Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Gyre Therapeutics (GYRE) over the last 12 years, with Q3 2025 value amounting to $866000.0.

  • Gyre Therapeutics' Non-Current Deffered Revenue rose 36810.81% to $866000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $866000.0, marking a year-over-year increase of 36810.81%. This contributed to the annual value of $928000.0 for FY2024, which is 33568.08% up from last year.
  • According to the latest figures from Q3 2025, Gyre Therapeutics' Non-Current Deffered Revenue is $866000.0, which was up 36810.81% from $884000.0 recorded in Q2 2025.
  • Over the past 5 years, Gyre Therapeutics' Non-Current Deffered Revenue peaked at $928000.0 during Q4 2024, and registered a low of $118000.0 during Q4 2022.
  • In the last 4 years, Gyre Therapeutics' Non-Current Deffered Revenue had a median value of $213000.0 in 2023 and averaged $499333.3.
  • As far as peak fluctuations go, Gyre Therapeutics' Non-Current Deffered Revenue soared by 8050.85% in 2023, and later skyrocketed by 36810.81% in 2025.
  • Gyre Therapeutics' Non-Current Deffered Revenue (Quarter) stood at $118000.0 in 2022, then surged by 80.51% to $213000.0 in 2023, then soared by 335.68% to $928000.0 in 2024, then fell by 6.68% to $866000.0 in 2025.
  • Its Non-Current Deffered Revenue stands at $866000.0 for Q3 2025, versus $884000.0 for Q2 2025 and $905000.0 for Q1 2025.